Pretreatment with eicosapentaenoic acid prevented hypoxia/reoxygenation-induced abnormality in endothelial gap junctional intercellular communication through inhibiting the tyrosine kinase activity

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 61, Issue 1, 1999, Pages 33-40

  Zhang, Y W ^a,b   Morita, I ^a   Yao, X S ^b   Murota, S ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CONNEXIN 43; ICOSAPENTAENOIC ACID; PHOSPHOPROTEIN; PROTEIN TYROSINE KINASE; TYROSINE; VANADIC ACID;

ARTICLE; CELL COMMUNICATION; CELL CULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME INHIBITION; GAP JUNCTION; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REOXYGENATION; UMBILICAL VEIN;

EID: 0032778410     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1054/plef.1999.0070     Document Type: Article

References (36)

1. Haught W. H., Mansour M., Rothlein R. Alterations in circulating intercellular adhesion molecule-1 and L-selectin: further evidence for chronic inflammation in ischemic heart disease. Am Heart J. 132:1996;1-8.
2. Boyle E. M. Jr, Lille S. T., Allaire E., Clowes A. W., Verrier E. D. Endothelial cell injury in cardiovascular surgery: atherosclerosis. Ann Thorac Surg. 63:1997;885-894.
3. Dimmeler S., Rippmann V., Weiland U., Haendeler J., Zeiher A. M. Angiotensin II induces apoptosis of human endothelial cells. Protective effect of nitric oxide. Circ Res. 81:1997;970-976.
4. Haller H. Endothelial function. General considerations. Drugs. 53:1997;1-10.
5. Schiffrin E. L. The endothelium and control of blood vessel function in health and disease. Clin Invest Med. 17:1994;602-620.
6. Lin S. J. Risk factors, endothelial cell turnover and lipid transport in atherogenesis. Clin Med J. 58:1996;309-316.
7. De Meyer G. R., Herman A. G. Vascular endothelial dysfunction. Prog Cardiovasc Dis. 39:1997;325-342.
8. McMillin J. B., Bick R. J., Benedict C. R. Influence of dietary fish oil on mitochondrial function and response to ischemia. Am J Physiol. 318:1992;H1479-H1485.
9. Yanagisawa A., Lefer A. M. Vasoactive effects of eicosapentaenoic acid on isolated vascular smooth muscle. Basic Res Cardiol. 82:1987;186-196.
10. Hayashi M., Nasa Y., Tanonaka K. The effects of long-term treatment with eicosapentaenoic acid and docosahexaenoic acid on hypoxia/reoxygenation injury of isolated cardiac cells in adult rats. J Mol Cell Cardiol. 27:1995;2031-2034.
11. Shiina T., Terano T., Saito J., Tamura Y., Yoshida S. Eicosapentaenoic acid and docosahexaenoic acid suppresses the proliferation of vascular smooth muscle cells. Atherosclerosis. 104:1993;95-103.
12. Terano T., Kobayashi S., Tamura Y., Yoshida S., Hirayama T. Changes in fatty acid composition, platelet aggregability and RBC function in elderly subjects with administration of low-dose of fish oil concentrate and comparison with younger subjects. Jpn J Geriatics. 31:1994;596-603.
13. Schjott J., Brurok H., Jynge P., Bjerve K. S. Effects of eicosapentaenoic acid and docosapentaenoic acid diet supplement on tolerance to the cardiotoxicity of epirubicin and ischaemia reperfusion in the isolated rat heart. Pharmacol Toxicol. 79:1996;65-72.
14. Nasa Y., Hayashi M., Sasaki H., Hayashi J., Takeo S. Long-term supplementation with eicosapentaenoic acid salvages cardiomyocytes from hypoxia/reoxygenation-induced injury in rats fed with fish-oil-deprived diet. Jpn J Pharmacol. 77:1998;137-146.
15. Durot I., Athias P., Dudot F., Grynberg A. Influence of phospholipid long chain polyunsaturated fatty acid composition on neonatal rat cardiomyocyte function in physiological conditions and during glucose-free hypoxia-reoxygenation. Mol Cell Biochem. 175:1997;253-262.
16. Kanayasu-Toyoda T., Morita I., Hibino H., Nakao-Hayashi J., Ito H., Murota S. Eicosapentaenoic acid abolishes the proatherogenic effects of cholesterol: effects on migration of bovine smooth muscle and endothelial cells in vitro. Prostaglandins Leukot Essent Fatty Acids. 48:1993;463-468.
17. Kanayasu-Toyoda T., Morita I., Murota S. Docosahexaenoic acid (22:5, n-3), an elongation metabolite of eicosapentaenoic acid (20:5, n-3), is a potent stimulator of endothelial cell migration on pretreatment in vitro. Prostaglandins Leukot Essent Fatty Acids. 54:1996;319-325.
18. Simanonok J. P. Non-ischemic hypoxia of the arterial wall is a primary cause of atherosclerosis. Med Hypotheses. 46:1996;155-161.
19. Bjornheden T., Evaldsson M., Wiklund O. A method for the assessment of hypoxia in the arterial wall, with potential application in vivo. Arterioscler Thromb Vasc Biol. 16:1996;178-185.
20. Santilli S. M., Fiegel V. D., Knighton D. R. Alloxan diabetes alters the rabbit transarterial wall oxygen gradient. J Vasc Surg. 18:1993;227-233.
21. Barker S. G., Talbert A., Cottam S., Barkerville P. A., Martin J. F. Arterial intimal hyperplasia after occlusion of the adventilial vasa vasorum in the pig. Arteroscler Thromb Vasc Biol. 13:1993;70-77.
22. Martin J. F., Booth R. F., Moncada S. Arterial wall hypoxia following thrombosis of the vasa vasorum is an initial lesion in atherosclerosis. Eur J Clin Invest. 21:1991;355-359.
23. Xie H., Laird D. W., Chang T. H., Hu V. W. A mitosis-specific phosphorylation of the gap junction protein connexin 43 in human vasvular cells: biochemical characterization and localization. J Cell Biol. 137:1997;203-210.
24. Laird D. W., Castillo M., Kasprzak L. Gap junction turnover, intracellular trafficking, and phosphorylation of connexin 43 in brefeldin A-treated rat mammary tumor cells. J Cell Biol. 131:1995;1193-1203.
25. Xie H. Q., Hu V. W. Modulation of gap junctions in senescent endothelial cells. Exp Cell Res. 214:1994;172-176.
26. Matesic D. F., Rupp H. L., Bonney W. J., Trosko S. E. Changes in gap-junction permeability, phosphorylation, and number mediated by phorbol ester and non-phorbol-ester tumor promoters in rat liver epithelial cells. Mol Carcinog. 10:1994;226-236.
27. Oudot F., Grynberg A., Sergiel J. P. Eicosanoid synthesis in cardiomyocytes: influence of hypoxia, reoxygenation, and polyunsaturated fatty acids. Am J Physiol. 268:1995;H308-H315.
28. Collie-Duguid E. S., Wahle K. W. Inhibitory effect of fish oil N-3 polyunsaturated fatty acids on the expression of endothelial cell adhesion molecules. Biochem Biophys Res Commun. 220:1996;969-974.
29. Nitta K., Uchida K., Tsutsui T., Honda K. Eicosapentaenoic acid inhibits mitogen-induced endothelin-1 production and DNA synthesis in cultured bovine mesangial cell. Am J Nephrol. 18:1998;164-170.
30. Van Rijen H. V. M., Van Kempen M. J. A., Analbers L. J. S. Gap junctions in human umbilical cord endothelial cells contain multiple connexins. Am J Physiol. 272:1997;C117-C130.
31. Hossain M. Z., Ao P., Boynton A. L. Platelet-derived growth factor-induced disruption of gap junctional communication and phosphorylation of connexin 43 involves protein kinase C and mitogen-activated protein kinase. J Cell Physiol. 174:1998;66-77.
32. Yeh H. I., Rothery S., Dupont E., Coppen S. R., Severs N. J. Individual gap junction plaques contain multiple connexins in arterial endothelium. Circ Res. 83:1998;1248-1263.
33. Terano T., Shiina T., Tamura Y. Eicosapentaenoic acid suppressed the proliferation of vascular smooth cells through modulation of various steps of growth signals. Lipids. 31:1996;301-304.
34. Sellmayer A., Danesch U., Weber P. C. Effects of different polyunsaturated fatty acids on growth-related early gene expression and cell growth. Lipids. 31:1996;37-40.
35. Speizer L. A., Watson M. J., Brunton L. L. Differential effects of omega-3 fish oils on protein kinase activaties in vitro. Am J Physiol. 261:1991;E109-E114.
36. Yang S. P., Morita I., Murota S. Eicosapentaenoic acid attenuates vascular endothelial growth factor-induced proliferation via inhibiting Flk-1 receptor expression in bovine carotial artery endothelial cells. J Cell Physiol. 176:1998;342-349.